Kenya Gastrointestinal Therapeutics Market Size, Share, Price, Trends, Growth, Analysis, Outlook, Report, Forecast 2023-2028

The Kenya Gastrointestinal Therapeutics Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Kenya Gastrointestinal Therapeutics market. This report explores all the key factors affecting the growth of the global Kenya Gastrointestinal Therapeutics market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141631/

Report Overview

The Gastrointestinal therapeutics market size in Kenya stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

According to World Health Organization (WHO), diarrhoea is one of the major causes of death among children under five years worldwide and it is classified as the second main cause of death. In Kenya, during the year 2018, 1,499,146 cases of diarrhoea were reported among children under five years. Among the cases of diarrhoea in 2018 in Kenya, Nairobi accounted for 136,028 cases. Risk Factors for Diarrhoea are contaminated drinking water, poor sanitation, personal hygiene, presence of open garbage or faeces near household and hand washing practice. Upper Gastrointestinal complaints among adults are common in Kenya. Peptic and Gastric ulcers are mainly caused by a bacterium - Helicobacter pylori. Inflammatory Gastrointestinal disorders like Ulcerative Colitis, Irritable/Inflammatory Bowel Syndrome may be attributed to lifestyle and dietary changes. Epidemiological surveys conducted in Kenya revealed high prevalence of Intestinal parasitic infections caused by Ascaris lumbricoides, Trichuris, Entamoeba histolytica, Giardia lamblia etc.

Market Drivers

The market is majorly driven by the rising burden of Gastrointestinal diseases in Kenya. A large proportion of Kenyas urban population live in slums with poor housing and sanitation. Living condition of urban slums is a major cause of diarrhoea among children and water-borne parasitic intestinal diseases.

Kenya is undergoing rapid urbanization and is among fastest growing economy in Eastern-Africa. Adoption of modern lifestyle and dietary changes in the urban population has led to increase in the incidence of inflammatory gastrointestinal disease like peptic ulcers and ulcerative colitis.

The prevalence of diarrhoea among children under five years in the households of urban informal settlements was 18.7%. High Prevalence of Diarrhoea and increasing incidence of inflammatory gastrointestinal diseases is expected to drive growth in the gastrointestinal therapeutics market in the forecast period.

However, low levels of awareness and increase in generic segment that is cost effective will lower the growth rate of the gastrointestinal therapeutics market.

To Know More About COVID-19 Impact On Kenya Gastrointestinal Therapeutics Market @ https://www.prudentmarkets.com/sample-request/141631/

Market Segmentation

By Disease Type:

On the basis of disease type, gastrointestinal therapeutics market in Kenya can be segmented into Diarrhoea, Peptic ulcers, Ulcerative Colitis, Gastroesophageal Reflux Disease (GERD), Irritable/Inflammatory Bowel Syndrome, Gastroenteritis, Intestinal Parasitic Infections and Others

By Drug Class:

On the basis of drug class, the Gastrointestinal therapeutics market can be segmented into antacids (Acid neutralizers), proton- pump inhibitors, anti-diarrhoeal drugs and laxatives, anti-parasitic, anti-inflammatory drugs and other drug classes.

By Mode of Prescription:

On the basis of mode of prescription, Gastrointestinal therapeutics market can be segmented into Prescription-Based Drugs and Over- The- Counter (OTC) drugs.

The OTC segment is expected to witness rapid growth rates throughout the forecast period.

By Distribution Channels:

On the basis of distribution channels, Gastrointestinal therapeutics market can be segmented into Hospital Pharmacies, Retail pharmacies, Online Pharmacies and others.

Major Players

Some of the prominent players in the gastrointestinal market are GlaxoSmithKline (GSK), Johnson & Johnson, Abbott Laboratories, Glenmark Pharmaceuticals and Novartis AG.

GSK is a leading drug supplier in Kenya in anti-infectives segment which is commonly the first line treatment for treating diarrhoeal infections in children.

Imodium (Loperamide) is used in the treatment of acute diarrhoea is sold by Janssen Pharmaceuticals ( A Johnson & Johnson Company).

Many domestic pharmaceutical companies in Kenya are leading in the manufacturing of gastrointestinal drugs like Dawa Limited, Cosmos Limited, Beta Healthcare, and Universal Pharmaceutical Limited.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141631/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global Kenya Gastrointestinal Therapeutics Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global Kenya Gastrointestinal Therapeutics Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Kenya Gastrointestinal Therapeutics market
Chapter 2: Exclusive Summary - the basic information of the Kenya Gastrointestinal Therapeutics Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Kenya Gastrointestinal Therapeutics
Chapter 4: Presenting the Kenya Gastrointestinal Therapeutics Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the Kenya Gastrointestinal Therapeutics market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/141631/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the Kenya Gastrointestinal Therapeutics Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.